By boosting CD4+ T-cell activation and antigen presentation, nanoparticles loaded with IL-12 (such as liposomes or hydrogels) trigger a robust anti-tumor immune response (Trinchieri, 2003). The gene discussed is CD4; the disease is neoplasm.